<

AURELIUS AG (FRA:AR4) AURELIUS Equity Opportunities co-invests in the acquisition of McKesson UK

Transparency directive : regulatory news

01/11/2021 13:02

DGAP-Ad-hoc: AURELIUS Equity Opportunities SE & Co. KGaA / Key word(s): Takeover
AURELIUS Equity Opportunities co-invests in the acquisition of McKesson UK

01-Nov-2021 / 13:02 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Inside Information according to Article 17 MAR

AURELIUS Equity Opportunities co-invests in the acquisition of McKesson UK

Grünwald, November 1, 2021 - AURELIUS Elephant Limited, a subsidiary of AURELIUS Equity Opportunities SE & Co. KGaA ("AEO"; ISIN: DE000A0JK2A8) and AURELIUS European Opportunities IV, S.C.A. ("AURELIUS European Opportunities Fund IV"), today signed a binding agreement to acquire the UK business activities of McKesson ("McKesson UK") from McKesson Corporation, Irving, Texas, in a corporate carve-out deal.

The deal with an enterprise value of GBP 477 million will be acquired through the recently launched co-investment structure with AURELIUS European Opportunities Fund IV controlling a 70% stake and AURELIUS Equity Opportunities SE & Co. KGaA (ISIN: DE000A0JK2A8) controlling 30%. The transaction is expected to close in Q1 2022, subject to customary closing conditions, including receipt of required regulatory approvals.

The McKesson UK business has an established position in the healthcare sector, comprising Lloyds Pharmacy as well as wholesale pharmaceuticals distributor, AAH Pharmaceuticals and generated over GBP 5 billion in revenues and an EBITDA in the high double-digit millions in 2020.

McKesson UK operates four divisions: retail, digital, homecare and wholesale. The business has over 18,000 employees, including pharmacists, nurses, logistics operatives as well as store, warehouse and administration personnel.

To find out more, visit www.aureliusinvest.com
 

CONTACT
AURELIUS Equity Opportunities SE & Co. KGaA
Investor Relations & Corporate Communications
Phone: +49 (89) 544799 - 0
Fax: +49 (89) 544799 - 55
E-mail: investor@aureliusinvest.de




 

01-Nov-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: AURELIUS Equity Opportunities SE & Co. KGaA
Ludwig-Ganghofer-Straße 6
82031 Grünwald
Germany
Phone: +49 (0)89 544 799-0
Fax: +49 (0)89 544 799-55
E-mail: info@aureliusinvest.de
Internet: www.aureliusinvest.de
ISIN: DE000A0JK2A8
WKN: A0JK2A
Listed: Regulated Unofficial Market in Berlin, Frankfurt, Hamburg, Munich (m:access), Stuttgart, Tradegate Exchange
EQS News ID: 1245133

 
End of Announcement DGAP News Service

1245133  01-Nov-2021 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1245133&application_name=news&site_id=symex


Other stories

28/03/2024 08:35
28/03/2024 12:00
28/03/2024 12:05
28/03/2024 10:23
28/03/2024 04:58
28/03/2024 07:36
28/03/2024 10:30
28/03/2024 12:16
28/03/2024 10:28
28/03/2024 08:00
28/03/2024 03:30
28/03/2024 10:57
28/03/2024 06:35
28/03/2024 10:39
28/03/2024 09:47
28/03/2024 07:06
28/03/2024 12:06
28/03/2024 08:52
27/03/2024 13:56
27/03/2024 01:33
27/03/2024 16:02
28/03/2024 10:31
28/03/2024 11:00
28/03/2024 10:13
28/03/2024 09:27
28/03/2024 07:27
28/03/2024 00:33
28/03/2024 10:05
27/03/2024 23:30
27/03/2024 23:14
27/03/2024 21:46
27/03/2024 20:21
28/03/2024 09:31
27/03/2024 20:12
28/03/2024 08:50
27/03/2024 23:00
28/03/2024 02:42
27/03/2024 15:35